Skip to main content
Livermore
Livermore
ZHEN

McIlrath & Eck, LLC

SEC CIK
0001701714
Latest filing
May 19, 2026

ABT holding history

Abbott Laboratories in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q1 2026 holdings

Shares (Q1 2026)
2,000
Value
$205.3K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ABT by McIlrath & Eck, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20262,000$205.3K<0.1%+185+10.2%AddedHolders
Q4 20251,815$227.4K<0.1%+719+65.6%AddedHolders
Q3 20251,096$146.8K<0.1%−26−2.3%ReducedHolders
Q2 20251,122$152.6K<0.1%+155+16.0%AddedHolders
Q1 2025967$128.3K<0.1%−129−11.8%ReducedHolders
Q4 20241,096$124.0K<0.1%−26−2.3%ReducedHolders
Q3 20241,122$127.9K<0.1%+26+2.4%AddedHolders
Q2 20241,096$113.9K<0.1%−137−11.1%ReducedHolders
Q1 20241,233$140.1K<0.1%+155+14.4%AddedHolders
Q4 20231,078$118.7K<0.1%00.0%UnchangedHolders
Q3 20231,078$104.4K<0.1%00.0%UnchangedHolders
Q2 20231,078$117.5K<0.1%−279−20.6%ReducedHolders
Q1 20231,357$137.4K<0.1%+142+11.7%AddedHolders
Q4 20221,215$133.4K<0.1%−188−13.4%ReducedHolders
Q3 20221,403$136.0K<0.1%00.0%UnchangedHolders
Q2 20221,403$152.0K<0.1%−192−12.0%ReducedHolders
Q1 20221,595$189.0K0.1%−25−1.5%ReducedHolders
Q4 20211,620$228.0K0.1%−410−20.2%ReducedHolders
Q3 20212,030$240.0K0.1%+10.0%AddedHolders
Q2 20212,029$235.0K0.1%−129−6.0%ReducedHolders
Q1 20212,158$259.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.